Effectiveness of community-based folate-oriented tertiary interventions on incidence of fetus and birth defects: a protocol for a single-blind cluster randomized controlled trial

BMC Pregnancy Childbirth. 2020 Aug 20;20(1):475. doi: 10.1186/s12884-020-03154-w.

Abstract

Background: Birth defects are the main cause of fetal death, infant mortality and morbidity worldwide. However, the etiology of birth defects remains largely unknown. Maternal folate status during periconception plays an important role in organogenesis and folic acid supplement reduces the risk of neural tube defects, congenital heart diseases, and several other birth defects. This trial seeks to evaluate the effectiveness of folate-oriented tertiary interventions during periconception on the incidence of fetus and birth defects.

Methods: This is a single-blind, two-arm cluster randomized controlled trial in Shanghai, China. Eligible women from 22 clusters are recruited at pre-pregnancy physical examinations clinical settings. Compared to the routine perinatal care group (control arm), folate-oriented tertiary interventions will be provided to the intervention arm. The core interventions consist of assessments of folate status and metabolism, folate intake guidance, and re-evaluation of folate status to ensure red blood cell folate level above 400 ng/ml (906 nmol/L) before pregnancy. Screening and consulting of fetus and birth defects, and treatments of birth defects during pregnancy and afterward will be provided to both arms. The primary outcome is a composite incidence of fetus defects, stillbirth, and neonatal birth defects identified from the confirmation of pregnancy to 28 days after birth. Secondary outcomes include maternal and offspring adverse complications and cost-effectiveness of folate-oriented tertiary interventions. This protocol adheres to the SPIRIT Checklist.

Discussion: To achieve the recommended folate status before or during pregnancy is still a challenge worldwide. This community-based cluster-randomized controlled intervention trial will evaluate the effectiveness of a package of interventions aiming at achieving recommended maternal folate status covering pre- and during pregnancy in reducing fetus and birth defects. Our study has the potential to improve the community-based practice of reducing modifiable risk factors of disease and improving primary prevention of the defects in China. The procedures would formulate the policy on folic acid supplementation during periconception against birth defects in primary care settings.

Trial registration: Clinical Trial Registry, NCT03725878 . Prospectively registered on 31 October 2018.

Keywords: Birth defects; Cluster randomized controlled trial; Periconception health care; Red blood cell folate; Serum folate; Study protocol.

Publication types

  • Clinical Trial Protocol

MeSH terms

  • Adolescent
  • Adult
  • China
  • Community Health Services / methods*
  • Congenital Abnormalities / prevention & control*
  • Dietary Supplements
  • Female
  • Folic Acid / therapeutic use*
  • Humans
  • Incidence
  • Infant, Newborn
  • Middle Aged
  • Neural Tube Defects / prevention & control
  • Perinatal Care
  • Preconception Care
  • Pregnancy
  • Randomized Controlled Trials as Topic
  • Single-Blind Method
  • Stillbirth
  • Vitamin B Complex / therapeutic use*
  • Young Adult

Substances

  • Vitamin B Complex
  • Folic Acid

Associated data

  • ClinicalTrials.gov/NCT03725878